Association of citalopram with congenital anomalies: A meta-analysis.

Hyun-Hye KangKi Hoon AhnSoon Cheol HongBo Yong KwonEun Hee LeeJi-Sung LeeMin-Jeong OhHai-Joong Kim

Published in: Obstetrics & gynecology science (2017)

From our data, it can be concluded that citalopram use is not associated with major birth defects. However, physicians should carefully weigh the benefits against the potential risks of citalopram use, and counsel patients accordingly.

Keyphrases

end stage renal disease
primary care
ejection fraction
human health
electronic health record
climate change
data analysis
preterm birth